Adjunctive Azithromycin Beneficial in C-Section Patients

This article originally appeared here.
Share this content:
Adjunctive Azithromycin Beneficial in C-Section Patients
Adjunctive Azithromycin Beneficial in C-Section Patients

THURSDAY, Sept. 29, 2016 (HealthDay News) -- Adding azithromycin to standard antibiotic therapy before a cesarean section reduces infection rates by 50 percent, according to a study published in the Sept. 29 issue of the New England Journal of Medicine.

William Andrews, Ph.D., M.D., of the University of Alabama at Birmingham, and colleagues recruited 2,013 women for the study. All were having a non-elective cesarean delivery and received the standard antibiotic therapy. About half were randomly assigned to also receive azithromycin. The rest were given an inactive placebo. The researchers looked for infections occurring within six weeks after delivery.

Over the study period, the primary outcome -- a composite of endometritis, wound infection, or other infection presenting within six weeks -- occurred in 6.1 percent of the women who received azithromycin, compared with 12.0 percent of the women who received the placebo. Endometritis occurred in 3.8 percent of the women given azithromycin, compared with 6.1 percent of those given a placebo. In addition, 2.4 percent of women given azithromycin developed infections at the site of the surgical incision, compared to 6.6 percent of those given a placebo. The corresponding rates for serious maternal adverse events were 1.5 and 2.9 percent.

"A simple approach involving the addition of a single dose of azithromycin, a relatively inexpensive and readily available antibiotic, to the recommended standard dose of a single antibiotic such as cefazolin is associated with a markedly lower rate of post-cesarean infection," Andrews told HealthDay.

Several authors disclosed financial ties to the pharmaceutical industry; the azithromycin used in the study was provided by Pfizer through an investigator-initiated grant.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Onabotulinum Toxin-A Can Safely Improve Sleep Bruxism

Onabotulinum Toxin-A Can Safely Improve Sleep Bruxism

Improved clinical global impression and change in visual analog scale, pain at 4 to 8 weeks post therapy

Professionals Disagree About Asking Patients About Sexuality

Professionals Disagree About Asking Patients About Sexuality

Article offers opposing views about recommendation in England to ask patients about sexual orientation

Value of Doxylamine-Pyridoxine Questioned in Early Pregnancy

Value of Doxylamine-Pyridoxine Questioned in Early Pregnancy

Greater improvement in symptom scores versus placebo, but clinical relevance unclear

is free, fast, and customized just for you!

Already a member?

Sign In Now »